Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

26 search results for igg

filterselect all | reset

Sort by

Order

Suggestions within Pfizer.com

Announcement

Article

Page

People Profiles

Podcast

Press Release

Product

filter select all | reset

Type

Announcement

Article

Page

People Profiles

Podcast

Press Release

Product

Date Range

Page 1
Page 2
Current page 3

Home
News
Press Releases

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

November 2008

11.25.2008
Pfizer’s Novel HIV/AIDS Treatment SELZENTRY™ Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients
11.19.2008
Pfizer Withdraws Application to Switch Viagra to Non-Prescription Status in Europe
11.13.2008
Pfizer Launches Global Regenerative Medicine Research Unit
11.11.2008
New Analysis Suggests That Improvements in Kidney Function in Patients Treated with Lipitor Strongly Correlate with a Reduced Risk of Major Cardiovascular Events
11.05.2008
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
11.05.2008
Pfizer Discontinues Development Program for Its Phase 3 Obesity Compound (CP-945,598)

October 2008

10.31.2008
Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder
10.26.2008
Pfizer's Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients
10.25.2008
Pfizer to Present Data on New Approaches to Pain and Inflammation Treatment at ACR Meeting
10.23.2008
Pfizer Declares a 32-Cent Fourth-Quarter 2008 Dividend
10.22.2008
Pfizer Completes Settlement Agreements with State Attorneys General Regarding its NSAID Pain Medications
10.21.2008
Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
10.20.2008
Pfizer Reports Third-Quarter 2008 Results
10.19.2008
Pfizer and UCB Announce Formation of New Company 'Cyclofluidic' to Accelerate Drug Discovery Process
10.16.2008
Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications
10.13.2008
New Data across Pfizer's Pain and Inflammation Portfolio to Be Presented at Upcoming ACR Meeting
10.09.2008
Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements over Four Years
10.09.2008
Aetna and Pfizer Present ''State of Motion'' Health Fair in Hartford to Encourage Families to Adopt Healthy Lifestyles
10.08.2008
EPA Honors Pfizer for Reducing Greenhouse Gas Emissions
10.03.2008
Pfizer Invites Public to View and Listen to Webcast of October 28 Analyst and Investor Meeting at ACR
10.01.2008
Pfizer Invites Public to View and Listen to Webcast of October 21 Conference Call with Analysts

September 2008

09.30.2008
Pfizer Shows Accelerating Pipeline with Significant Growth in Late-Stage Clinical Development
09.24.2008
Established Safety Profile of Spiriva(R) Confirmed by 30 Rigorously Controlled Clinical Trials
09.23.2008
Grameen Health and Pfizer Announce Novel Partnership to Explore Sustainable Healthcare Delivery Models for the Developing World
09.22.2008
Pfizer Recognized as Leader in Improving Climate Change for Second Consecutive Year
09.15.2008
MannKind and Pfizer Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy
09.15.2008
Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options
09.14.2008
Pfizer Oncology Presents Safety and Efficacy Results Of CP-751,871 Study At ESMO 2008
09.10.2008
Pfizer Animal Health Adds Former Schering-Plough Products to European Portfolio
09.08.2008
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
09.08.2008
Data to Be Presented At ESMO 2008 Highlight Pfizer Commitment to Cancer Care and Research
09.08.2008
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
09.02.2008
Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon for the Treatment of Alzheimer's and Huntington's Diseases
09.01.2008
Lipitor 80 mg Provided Sustained Risk Reduction of Cardiovascular Events in Patients with Heart Disease During the Five-Year TNT Trial
09.01.2008
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients

August 2008

08.28.2008
Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before November 2011
08.26.2008
Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program
08.14.2008
Pfizer Says Vacation with Your Dog before the Summer Ends
08.11.2008
IAFF Launches Smoking Cessation Campaign with Pfizer
08.06.2008
Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke in Patients with Heart Disease, Type 2 Diabetes and Chronic Kidney Disease

July 2008

07.22.2008
Pfizer Reports Second-Quarter 2008 Results
07.13.2008
Pfizer to Showcase Alzheimer's Research and Pipeline at Upcoming Alzheimer's Disease Medical Meeting
07.09.2008
Pfizer Fully Supports Updated PhRMA Code
07.06.2008
Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows
07.01.2008
Pfizer Changes Its Funding of Continuing Medical Education in the U.S.

June 2008

06.29.2008
FDA Approves First and Only Single-Dose Antibiotic for Dogs and Cats
06.25.2008
Pfizer Declares a 32-Cent Third Quarter 2008 Dividend
06.25.2008
Pfizer Invites Public to View and Listen to Webcast of July 23 Conference Call with Analysts

Page 48
Page 49
Current page 50
Page 51
Page 52

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube